Top Markets
Coin of the day
Neovasc Inc. Neovasc Inc.

Neovasc Inc.

NVCN
Rang in Aktien #17840
Neovasc Inc. is a medical technology firm specializing in the design,... Neovasc Inc. is a medical technology firm specializing in the design, production, and global distribution of cardiovascular devices, particularly across European markets and beyond. Its primary offerings include the Tiara system, developed for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer, used to address chronic, debilitating chest pain known as refractory angina. Established in 2000, the company, which maintains its headquarters in Richmond, Canada, was formerly named Medical Ventures Corp. before adopting its current identity, Neovasc Inc., in July 2008.
Aktienkurs
$29.82
Zuletzt synchronisiert: 2023-04-11
Marktkapitalisierung
$223.68M
Veränderung (1 Tag)
1.21%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel Neovasc Inc. (NVCN)

Kategorie

Kursverlauf für Neovasc Inc. (NVCN)
Höchster Schlusskurs: $29.60 am 2023-04-01

Niedrigster Schlusskurs: $112.36K am 2001-05-01
Kursverlauf der Aktie von Neovasc Inc. von 2001 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2023 172.80%
2022 -25.78%
2021 -31.79%
2020 -74.55%
2019 -50.59%
2018 -98.94%
2017 -64.07%
2016 -55.36%
2015 -36.86%
2014 67.21%
2013 128.15%
2012 15.35%
2011 43.26%
2010 185.91%
2009 230.48%
2008 -93.29%
2007 -55.72%
2006 -51.21%
2005 -33.47%
2004 -27.51%
2003 49.66%
2002 62.92%
2001 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$110.59 -16.34%
US
$312.39 -19.60%
US
$92.11 -0.15%
IE
$48.42 -54.97%
US
$90.87 11.88%
US